A few of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made huge purchases on Thursday. Altogether, these funds bought nearly a million shares of UiPath Inc. (NYSE: PATH | PATH Price Prediction), as the price of these ETFs lost more than 4% on the day. Note that these funds are mostly down over the past year, with one big exception.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 245,247 shares of the robotics software firm, ARK Innovation ETF (NYSEARCA: ARKK) purchased 430,278 shares, ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKQ) picked up 100,124 shares and ARK Next Generation Internet ETF (NYSEARCA: ARKW) added 194,241 shares. At Thursday’s closing price, this would have valued these purchases at roughly $45.6 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. While the robotics fund is up around 12% in the past year, the others are down between 7% and 32% in the same time.
[nativounit]
Check out all the ARK Invest purchases for Thursday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKG | PATH | UIPATH | 245,247 |
| ARKG | NTLA | INTELLIA THERAPEUTICS | 8,315 |
| ARKG | SLGC | SOMALOGIC | 33,736 |
| ARKG | QSI | QUANTUM-SI | 39,948 |
| ARKG | NVTA | INVITAE | 3,000 |
| ARKK | PATH | UIPATH | 430,278 |
| ARKK | SSYS | STRATASYS | 164,886 |
| ARKK | NTLA | INTELLIA THERAPEUTICS | 27,900 |
| ARKK | DNA | GINKGO BIOWORKS | 223,347 |
| ARKK | VCYT | VERACYTE | 49,861 |
| ARKK | NVTA | INVITAE | 100,000 |
| ARKK | MTLS | MATERIALISE | 27,783 |
| ARKK | TRMB | TRIMBLE | 4,455 |
| ARKQ | PATH | UIPATH | 100,124 |
| ARKQ | AVAV | AEROVIRONMENT | 58,300 |
| ARKQ | VUZI | VUZIX | 43,948 |
| ARKQ | BLDE | BLADE AIR MOBILITY | 5,637 |
| ARKW | PATH | UIPATH | 194,241 |
| ARKW | VUZI | VUZIX | 77,016 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=1010349][wallst_email_signup]
Top Gaining Stocks
Top Losing Stocks